🇺🇸 FDA
Patent

US 7265083

Treatment of idiopathic pulmonary fibrosis using IP-10

granted A61KA61K2039/505A61K38/195

Quick answer

US patent 7265083 (Treatment of idiopathic pulmonary fibrosis using IP-10) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2039/505, A61K38/195, A61K38/2053, A61K48/00